Skip to content
Life Sciences Series A Founded 2016

FYR Diagnostics

Provider of in-vitro diagnostic tests for the detection of diseases. The company develops a portfolio of biomarker detection technologies with a focus on nucleic acid amplification that enables the accelerated prediction, diagnosis, and management of human and agricultural diseases. The company was founded in 2016 and headquartered in Missoula, United States. It has raised $8M in series a funding, with backing from…

📍 Missoula, United States · Genomics,

Funding snapshot

Last roundSeries A
Amount$8M
Date2 August 2024
Total raised$8M
Team size17

About

Provider of in-vitro diagnostic tests for the detection of diseases. The company develops a portfolio of biomarker detection technologies with a focus on nucleic acid amplification that enables the accelerated prediction, diagnosis, and management of human and agricultural diseases. The company was founded in 2016 and headquartered in Missoula, United States. It has raised $8M in series a funding, with backing from America’s Seed Fund, HHS, Two Bear Capital, MonTEC. The company operates in the Life Sciences - Genomics, Life Sciences - Hematology space. Its offerings span Hematology - In Vitro Diagnostics Tests - Diversified and Genomics - Genomics Research - Biomarker Discovery.

Business model

Hematology > In Vitro Diagnostics Tests > Diversified,

Genomics > Genomics Research > Biomarker Discovery

Institutional investors

America’s Seed Fund HHS Two Bear Capital MonTEC

Latest coverage

No articles yet.

Raising like FYR Diagnostics?

Analyze your pitch deck before your next raise.

Analyze My Deck →